Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients

INTRODUCTION: Many studies have highlighted the important role of PCSK9 in the development of cardiometabolic changes and its possible function as a biomarker of myocardial infarction or ischemic heart disease. This study aimed to determine the relationship between circulating PCSK9 levels and subcl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tóth, Štefan, Fedačko, Ján, Pekárová, Tímea, Hertelyová, Zdenka, Katz, Matan, Mughees, Adil, Kuzma, Jozef, Štefanič, Peter, Kopolovets, Ivan, Pella, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688969/
https://www.ncbi.nlm.nih.gov/pubmed/28623549
http://dx.doi.org/10.1007/s40119-017-0092-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688969/
https://www.ncbi.nlm.nih.gov/pubmed/28623549
http://dx.doi.org/10.1007/s40119-017-0092-8

Ejemplares similares